Pharmacokinetics (PK) of lonafarnib (L), a farnesyl protein transferase inhibitor.

被引：0
|
作者：
Zhu, Y [1 ]
Statkevich, P [1 ]
Cutler, DL [1 ]
Calzetta, A [1 ]
Curtis, D [1 ]
Batra, VK [1 ]
机构：
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 75卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P59 / P59
页数：1
相关论文
共 50 条
  • [21] Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia:: a phase II study
    Ravoet, Christophe
    Mineur, Philippe
    Robin, Valerie
    Debusscher, Louisette
    Bosly, Andre
    Andre, Marc
    El Housni, Hakim
    Soree, Anne
    Bron, Dominique
    Martiat, Philippe
    ANNALS OF HEMATOLOGY, 2008, 87 (11) : 881 - 885
  • [22] Synthesis of a novel, selective and farnesyl pyrophosphate competitive farnesyl-protein transferase inhibitor
    Shibata, J
    Aoyama, T
    Kawakami, K
    Arai, S
    Iwasawa, Y
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 54 - MEDI
  • [23] R-115777 -: Oncolytic farnesyl protein transferase inhibitor
    Sorbera, LA
    Fernéndez, R
    Castañer, J
    DRUGS OF THE FUTURE, 2001, 26 (05) : 453 - 461
  • [24] Synthesis routes towards the farnesyl protein transferase inhibitor ZARNESTRA™
    Angibaud, PR
    Venet, MG
    Filliers, W
    Broeckx, R
    Ligny, YA
    Muller, P
    Poncelet, VS
    End, DW
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2004, 2004 (03) : 479 - 486
  • [25] Synthetic studies of farnesyl protein transferase inhibitor pepticinnamin E
    Deng, JG
    Sun, DQ
    Lin, XQ
    Mi, AQ
    Jiang, YZ
    PEPTIDES: BIOLOGY AND CHEMISTRY, 2000, : 163 - 165
  • [26] Preliminary pharmacokinetics (PK) of COL-3, a matrix metalloproteinase (MMP) inhibitor.
    Rudek, MA
    Dyer, V
    Hamilton, JM
    Pluda, JM
    Reed, E
    Figg, WD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 195 - 195
  • [27] Synthesis of A-228839.25, farnesyl transferese inhibitor.
    Premchandran, RH
    Bhagavatula, L
    Mcdermott, T
    Bailey, AE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U56 - U56
  • [28] Phase I trial of the farnesyl protein transferase (FPTASE) inhibitor L-778123 in combination with radiotherapy
    Hahn, SM
    Kiel, K
    Morrison, BW
    Mohiuddin, M
    Delaney, TF
    Smith, D
    Brown, R
    Pramanik, B
    Deutsch, P
    Bernhard, E
    Muschel, R
    McKenna, G
    CLINICAL CANCER RESEARCH, 2000, 6 : 4481S - 4481S
  • [29] Farnesyl protein transferase inhibitors
    Terrett, N
    DRUG DISCOVERY TODAY, 1997, 2 (11) : 499 - 499
  • [30] Oreganic acid, a potent inhibitor of Ras farnesyl-protein transferase
    Silverman, KC
    Jayasuriya, H
    Cascales, C
    Vilella, D
    Bills, GF
    Jenkins, RG
    Singh, SB
    Lingham, RB
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 232 (02) : 478 - 481
12345